Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 9:22 PM
Ignite Modification Date:
2025-12-24 @ 9:22 PM
NCT ID:
NCT02615704
Eligibility Criteria:
Inclusion Criteria:
* Provision of signed and dated patient informed consent prior to randomisation
* Female or male aged 18 years or older
* Acute Coronary Syndrome patients, diagnosed with ST elevation myocardial infarction, non-ST elevation myocardial infarction or unstable angina pectoris treated with Brilique (ticagrelor) prior to inclusion into this study and for whom the treating physician intends to continue prescribing twice daily Brilique (ticagrelor) co administered with low dose acetylsalicylic acid according to the prescription recommendation, within 14 days following the diagnosis of the ACS event
* Ability to read, understand and write German
* Patients must have access to an electronic device (compatible with the patient support tool) and willing to use it on a daily basis
Exclusion Criteria:
* Involvement in the planning and/or conduct of the study (applies to AstraZeneca staff and/or staff at the study site and application developer)
* Participation in another clinical study with an investigational product or medical device during the last 30 days, excluding prospective/retrospective register based studies that do not require any extra visits in addition to ordinary health care
* Patients on treatment with Oral Anti-Platelet drugs other than Brilique (ticagrelor)
* Patients with contraindication to the use of Brilique (ticagrelor)
* Patients accepted/with a plan for thoracic surgery (coronary artery bypass grafting, CABG) or any other elective surgery that cannot be postponed until after study participation
* Presence of serious/severe co-morbidities in the opinion of the Investigator which may limit life expectancy (\<1 year)
* For women only: patients who are currently pregnant (confirmed with positive pregnancy test) or breast feeding
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
130 Years
Study:
NCT02615704
Study Brief:
Protocol Section:
NCT02615704